Disease Overview：Azoospermia（AZS）
Azoospermia is a male infertility condition characterized by the complete absence of sperm in the ejaculate, confirmed through centrifuged semen analysis on at least two separate occasions. It affects approximately 1% of men and accounts for 10–15% of male infertility cases. Azoospermia is broadly classified into obstructive (OA), where sperm production is normal but transport is impeded—often due to congenital absence of the vas deferens, infection, or prior surgery—and non-obstructive (NOA), resulting from impaired spermatogenesis due to genetic abnormalities (e.g., Klinefelter syndrome, Y-chromosome microdeletions), hormonal imbalances, or testicular failure. Diagnosis requires comprehensive evaluation: hormonal profiling (FSH, testosterone, inhibin B), genetic testing (karyotype, AZF region analysis), scrotal ultrasound, and, when indicated, testicular sperm extraction (TESE) or microdissection TESE (micro-TESE).
China offers distinct advantages for azoospermia management: leading urology-and-andrology centers—many affiliated with top-tier academic hospitals—employ advanced microsurgical techniques, high-resolution imaging, and next-generation genetic diagnostics. Micro-TESE success rates for sperm retrieval in NOA patients exceed 50% in experienced centers, with robust IVF/ICSI integration. Treatment costs are typically 40–60% lower than in the US or Western Europe, without compromising clinical standards or outcomes. As a dedicated medical tourism agency, we facilitate seamless international care—vetting JCI-accredited hospitals, coordinating appointments with board-certified andrologists, providing transparent, all-inclusive pricing, and offering end-to-end support including visa assistance, translation, accommodation, and post-procedure follow-up.
Azoospermia: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown for Azoospermia (Male Infertility)
Non-Surgical / Conservative / Medication Options
*Target: Hormonal azoospermia (e.g., hyperprolactinemia, hypogonadotropic hypogonadism) or reversible obstructive causes.*
- •Prolactin-lowering therapy (Bromocriptine/Cabergoline):
- Cost: ¥120–¥380/month ($17–$54); 3–6 months required.
- •hCG/hMG gonadotropin therapy:
- Cost: hCG (2,000 IU × 3×/week) + hMG (75 IU × 3×/week) for 6–12 months: ¥4,200–¥12,600 total ($595–$1,785).
- •Pre-treatment diagnostics:
- Pituitary MRI (non-contrast): ¥720 ($102) - Semen analysis ×2 (post-therapy): ¥160 × 2 = ¥320 ($45)
Surgical / Procedural / Interventional Options
*Target: Obstructive azoospermia (OA) or non-obstructive azoospermia (NOA) with focal spermatogenesis.*
- •Percutaneous Epididymal Sperm Aspiration (PESA):
- Procedure cost: ¥3,500–¥5,800 ($495–$820)
- •Testicular Sperm Extraction (TESE):
- Cost: ¥6,200–¥9,500 ($875–$1,345)
- •Micro-TESE (gold standard for NOA):
- Cost: ¥12,800–¥18,500 ($1,810–$2,620)
- •Preoperative workup (mandatory for all procedures):
- Genetic testing (karyotype + Y-microdeletion): ¥1,450 ($205) - CBC, coagulation panel, ECG: ¥480 ($68)
Special / Complex Condition Management
- •Klinefelter syndrome (47,XXY) with mosaicism: Micro-TESE success rate ~40–50%; cost same as standard Micro-TESE (¥12,800–¥18,500).
- •Post-chemotherapy/radiation NOA: Requires ≥2-year wait + hormonal priming; Micro-TESE cost ¥15,200–¥18,500 ($2,150–$2,620) due to extended OR time.
- •Congenital bilateral absence of vas deferens (CBAVD): PESA + CFTR gene testing (¥680/$96); total procedural cost ¥4,200–¥6,500 ($595–$920).
Quick Selection Guide
- •<35 years, budget < $1,000, confirmed OA: PESA + ICSI — fastest path, lowest cost.
- •35–42 years, FSH 10–25 IU/L, NOA: Micro-TESE — highest sperm retrieval rate (50–60%).
- •>42 years or severe comorbidities (COPD, uncontrolled HTN): Hormonal therapy trial first (if endocrine cause suspected); avoid surgery unless strong candidacy.
- •Budget-constrained NOA (FSH <15 IU/L): TESE over Micro-TESE — saves $935–$1,745 with ~15% lower retrieval rate.
- •Klinefelter or prior oncology history: Micro-TESE mandatory; prioritize high-volume urology centers (e.g., PUMCH, Ruijin Hospital) despite premium pricing.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Azoospermia Medical Vacation Packages
Curated transparent all-inclusive packages combining Azoospermia treatment with China top medical destinations:
